The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company has โน1.024 Trillion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | โน1.027 T | 12.74% |
2023-12-31 | โน911.07 B | 18.32% |
2022-12-31 | โน769.98 B | 28.72% |
2021-12-31 | โน598.20 B | -23.18% |
2020-12-31 | โน778.65 B | 22.54% |
2019-12-31 | โน635.45 B | -68.99% |
2018-12-31 | โน2.049 T | -23% |
2017-12-31 | โน2.661 T | 2.83% |
2016-12-31 | โน2.588 T | 24.1% |
2015-12-31 | โน2.085 T | 21.76% |
2014-12-31 | โน1.712 T | 42.91% |
2013-12-31 | โน1.198 T | -9.02% |
2012-12-31 | โน1.317 T | 20.65% |
2011-12-31 | โน1.091 T | 39.87% |
2010-12-31 | โน780.67 B | 25.17% |
2009-12-31 | โน623.70 B | 35.85% |
2008-12-31 | โน459.11 B | 63.6% |
2007-12-31 | โน280.64 B | 0.95% |
2006-12-31 | โน278.00 B | 17.56% |
2005-12-31 | โน236.47 B | -5.99% |
2004-12-31 | โน251.53 B | 7.84% |
2003-12-31 | โน233.25 B | 4.29% |
2002-12-31 | โน223.65 B | 74.12% |
2001-12-31 | โน128.45 B | 35.71% |
2000-12-31 | โน94.65 B | 63.34% |
1999-12-31 | โน57.94 B | 577.71% |
1998-12-31 | โน8.55 B | -9% |
1997-12-31 | โน9.39 B | 54.39% |
1996-12-31 | โน6.08 B |